DVC Deutsche Venture Capital

DVC Deutsche Venture Capital was a prominent German venture capital firm and a subsidiary of Deutsche Bank, primarily active during the late 1990s and early 2000s. The firm specialized in early-stage and growth-stage investments within the life sciences and information technology sectors, playing a pivotal role in the European biotech landscape. Its life science portfolio included notable companies such as Micromet, GPC Biotech, Paion, and 4SC. Following a strategic reorganization within Deutsche Bank's asset management division in the mid-2000s, DVC ceased making new investments and its existing portfolio was managed toward exit or integrated into other units. The firm was instrumental in providing the capital necessary for several German biotech companies to reach the public markets or achieve significant clinical milestones.